Qi Zhou, Yelei Gao, Xingmei Wang, R. Liu, Peipei Du, Xiaoqing Wang, Xianzhuo Zhang, S. Lu, Zijun Wang, Q. Shi, Weiguo Li, Yanfang Ma, Xufei Luo, T. Fukuoka, H. Ahn, Myeong Soo Lee, E. Liu, Yaolong Chen, Z. Luo, Kehu Yang
{"title":"Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis","authors":"Qi Zhou, Yelei Gao, Xingmei Wang, R. Liu, Peipei Du, Xiaoqing Wang, Xianzhuo Zhang, S. Lu, Zijun Wang, Q. Shi, Weiguo Li, Yanfang Ma, Xufei Luo, T. Fukuoka, H. Ahn, Myeong Soo Lee, E. Liu, Yaolong Chen, Z. Luo, Kehu Yang","doi":"10.1101/2020.04.14.20065730","DOIUrl":null,"url":null,"abstract":"Background: COVID-19, a disease caused by SARS-CoV-2 coronavirus, has now spread to most countries and regions of the world. As patients potentially infected by SARS-CoV-2 need to visit hospitals, the incidence of nosocomial infection can be expected to be high. Therefore, a comprehensive and objective understanding of nosocomial infection is needed to guide the prevention and control of the epidemic. Methods: We searched major international and Chinese databases Medicine, Web of science, Embase, Cochrane, CBM(China Biology Medicine disc), CNKI (China National Knowledge Infrastructure) and Wanfang database)) for case series or case reports on nosocomial infections of COVID-19, SARS(Severe Acute Respiratory Syndromes) and MERS(Middle East Respiratory Syndrome) from their inception to March 31st, 2020. We conducted a meta-analysis of the proportion of nosocomial infection patients in the diagnosed patients, occupational distribution of nosocomial infection medical staff and other indicators. Results: We included 40 studies. Among the confirmed patients, the proportions of nosocomial infections were 44.0%, 36.0% and 56.0% for COVID-19, SARS and MERS, respectively. Of the confirmed patients, the medical staff and other hospital-acquired infections accounted for 33.0% and 2.0% of COVID-19 cases, 37.0% and 24.0% of SARS cases, and 19.0% and 36.0% of MERS cases, respectively. Nurses and doctors were the most affected among the infected medical staff. The mean numbers of secondary cases caused by one index patient were 29.3 and 6.3 for SARS and MERS, respectively. Conclusions: The proportion of nosocomial infection in patients with COVID-19 was 44%. Patients attending hospitals should take personal protection. Medical staff should be awareness of the disease to protect themselves and the patients. Keywords: COVID-19; meta-analysis; nosocomial infection; rapid review.","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"171","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of translational medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1101/2020.04.14.20065730","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 171
Abstract
Background: COVID-19, a disease caused by SARS-CoV-2 coronavirus, has now spread to most countries and regions of the world. As patients potentially infected by SARS-CoV-2 need to visit hospitals, the incidence of nosocomial infection can be expected to be high. Therefore, a comprehensive and objective understanding of nosocomial infection is needed to guide the prevention and control of the epidemic. Methods: We searched major international and Chinese databases Medicine, Web of science, Embase, Cochrane, CBM(China Biology Medicine disc), CNKI (China National Knowledge Infrastructure) and Wanfang database)) for case series or case reports on nosocomial infections of COVID-19, SARS(Severe Acute Respiratory Syndromes) and MERS(Middle East Respiratory Syndrome) from their inception to March 31st, 2020. We conducted a meta-analysis of the proportion of nosocomial infection patients in the diagnosed patients, occupational distribution of nosocomial infection medical staff and other indicators. Results: We included 40 studies. Among the confirmed patients, the proportions of nosocomial infections were 44.0%, 36.0% and 56.0% for COVID-19, SARS and MERS, respectively. Of the confirmed patients, the medical staff and other hospital-acquired infections accounted for 33.0% and 2.0% of COVID-19 cases, 37.0% and 24.0% of SARS cases, and 19.0% and 36.0% of MERS cases, respectively. Nurses and doctors were the most affected among the infected medical staff. The mean numbers of secondary cases caused by one index patient were 29.3 and 6.3 for SARS and MERS, respectively. Conclusions: The proportion of nosocomial infection in patients with COVID-19 was 44%. Patients attending hospitals should take personal protection. Medical staff should be awareness of the disease to protect themselves and the patients. Keywords: COVID-19; meta-analysis; nosocomial infection; rapid review.
背景:COVID-19是一种由SARS-CoV-2冠状病毒引起的疾病,目前已蔓延到世界上大多数国家和地区。由于潜在感染SARS-CoV-2的患者需要到医院就诊,预计医院感染的发生率将很高。因此,需要全面客观地了解医院感染情况,指导疫情防控工作。方法:检索国内外主要数据库Medicine、Web of science、Embase、Cochrane、CBM(中国生物医学数据库)、CNKI(中国国家知识基础设施)和万方数据库,检索自2019冠状病毒病(COVID-19)、SARS(严重急性呼吸综合征)和MERS(中东呼吸综合征)成立至2020年3月31日的医院感染病例系列或病例报告。我们对医院感染患者占确诊患者的比例、医院感染医务人员职业分布等指标进行meta分析。结果:我们纳入了40项研究。确诊患者中,新冠肺炎、SARS和MERS的院内感染比例分别为44.0%、36.0%和56.0%。在确诊病例中,医务人员和其他医院获得性感染分别占COVID-19病例的33.0%和2.0%,占SARS病例的37.0%和24.0%,占MERS病例的19.0%和36.0%。护士和医生是受感染最严重的医务人员。SARS和MERS平均每一指标患者继发病例数分别为29.3例和6.3例。结论:2019冠状病毒病患者发生医院感染的比例为44%。到医院就诊的患者应做好个人防护。医务人员应提高疾病意识,保护自己和患者。关键词:COVID-19;荟萃分析;院内感染;快速复习。
期刊介绍:
The Annals of Translational Medicine (Ann Transl Med; ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) is an international, peer-reviewed Open Access journal featuring original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical up-to-date information in significant research from all subspecialties of medicine and to broaden the readers’ vision and horizon from bench to bed and bed to bench. It is published quarterly (April 2013- Dec. 2013), monthly (Jan. 2014 - Feb. 2015), biweekly (March 2015-) and openly distributed worldwide. Annals of Translational Medicine is indexed in PubMed in Sept 2014 and in SCIE in 2018. Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy. With a focus on interdisciplinary academic cooperation, ATM aims to expedite the translation of scientific discovery into new or improved standards of management and health outcomes practice.